Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

NVO

Novo Resources (NVO)

Novo Resources Corp
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:TSX:NVO
FechaHoraFuenteTítuloSímboloCompañía
28/08/202311:14PR Newswire (Canada)Suspension de la négociation par l'Organisme canadien de réglementation des investissements - NVO.WTTSX:NVONovo Resources Corp
28/08/202311:10PR Newswire (Canada)Canadian Investment Regulatory Organization Trading Halt - NVO.WTTSX:NVONovo Resources Corp
05/02/202108:00PR Newswire (Canada)TMX Group Equity Financing Statistics - January 2021TSX:NVONovo Resources Corp
16/02/201007:00PR Newswire (US)Novo Nordisk Makes Victoza(R) Commercially Available in the United StatesNYSE:NVO
21/01/201014:49PR Newswire (US)Novo Nordisk Makes FORTUNE's List of '100 Best Companies to Work For'NYSE:NVO
14/01/201002:01PR Newswire (US)Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper DemonstratesNYSE:NVO
13/01/201008:43PR Newswire (US)/K I L L K I L L K I L L - National Changing Diabetes Program/NYSE:NVO
02/12/200908:00PR Newswire (US)FDA Approves 10 mcg Dose of Vagifem(R) for the Treatment of Atrophic Vaginitis Due to MenopauseNYSE:NVO
27/11/200908:30PR Newswire (US)Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study ShowsNYSE:NVO
19/11/200907:00PR Newswire (US)Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results ShowNYSE:NVO
30/10/200908:00PR Newswire (US)Novo Nordisk is Changing Possibilities in HemophiliaNYSE:NVO
20/10/200907:30PR Newswire (US)Data Analysis Reinforces the Safety Profile of Levemir(R)NYSE:NVO
01/09/200908:58PR Newswire (US)Research Supports Improving 'Scoring' of Costs and Benefits of Preventive Health Care to Better Inform Federal Budgetary DecisioNYSE:NVO
01/09/200907:00PR Newswire (US)National Changing Diabetes Program Supports Improvements in Health Cost EstimatesNYSE:NVO
27/08/200908:03PR Newswire (US)Patient Education Summits to Address Special Challenges of Hemophilia Patients and Their FamiliesNYSE:NVO
12/08/200909:00PR Newswire (US)Dwayne Johnson, Novo Nordisk and the Entertainment Industry Foundation Educate Families about Healthy Living and DiabetesNYSE:NVO
10/08/200908:00PR Newswire (US)Photos: Norditropin NordiFlex(R) 30 mg/3 mL Prefilled Pen Offers Children Needing a Larger Dose of Growth Hormone a Convenient ONYSE:NVO
05/08/200907:30PR Newswire (US)Novo Nordisk Appoints Per Falk, M.D., Ph.D., as Vice President for Clinical, Medical and Regulatory Affairs for North AmericaNYSE:NVO
23/07/200908:00PR Newswire (US)NCDP Health Care Reform Recommendations Advocate for Diabetes Prevention, Treatment and CareNYSE:NVO
15/07/200912:43PR Newswire (US)FDA Approves NovoLog(R) Labeling UpdateNYSE:NVO
13/07/200912:51PR Newswire (US)Diabetes Advocates Call For National Strategy, Leadership to Reduce Diabetes and Advance Detection and TreatmentNYSE:NVO
28/06/200914:18PR Newswire (US)Novo Nordisk Insulin Analogs Have Proven Safety ProfilesNYSE:NVO
13/06/200912:09PR Newswire (US)Novo Nordisk Warns Customers About Stolen InsulinNYSE:NVO
12/06/200909:25PR Newswire (US)Novo Nordisk Convenes Policy and Clinical Experts at Diabetes Media SummitNYSE:NVO
08/06/200916:50PR Newswire (US)The Lancet Publishes Direct Comparison Study Between Liraglutide and ExenatideNYSE:NVO
08/06/200907:00PR Newswire (US)Two-Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than GlimepirideNYSE:NVO
07/06/200909:00PR Newswire (US)Two-Year Data Show Investigational Drug Liraglutide More Effective at Lowering Blood Sugar Than Glimepiride: Oral 162NYSE:NVO
20/05/200912:21PR Newswire (US)Americans Who Don't Know They Have Diabetes Incur $18 Billion in Health Expenses Each YearNYSE:NVO
18/05/200906:00PR Newswire (US)Video: Academy Award(R) Winner Olympia Dukakis and Husband, Actor Louis Zorich, Encourage Older Adults to Ask.Screen.Know.NYSE:NVO
08/05/200908:14PR Newswire (US)Photo: Levemir(R) Once-Daily Substantially Lowered Average Blood Sugar Levels of Patients with Type 2 Diabetes in TITRATE(R) StuNYSE:NVO
 Showing the most relevant articles for your search:TSX:NVO

Su Consulta Reciente

Delayed Upgrade Clock